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Maintenance of a constant cell volume in response
to extracellular or intracellular osmotic changes is
critical for cellular homeostasis. Activation of a ubiq-
uitous volume-regulated anion channel (VRAC) plays
a key role in this process; however, its molecular
identity in vertebrates remains unknown. Here, we
used a cell-based fluorescence assay and performed
a genome-wide RNAi screen to find components
of VRAC. We identified SWELL1 (LRRC8A), a
member of a four-transmembrane protein family
with unknown function, as essential for hypotonici-
ty-induced iodide influx. SWELL1 is localized to the
plasma membrane, and its knockdown dramatically
reduces endogenous VRAC currents and regulatory
cell volume decrease in various cell types. Further-
more, point mutations in SWELL1 cause a significant
change in VRAC anion selectivity, demonstrating that
SWELL1 is an essential VRAC component. These
findings enable further molecular characterization
of the VRAC channel complex and genetic studies
for understanding the function of VRAC in normal
physiology and disease.
INTRODUCTION
The plasma membrane of most animal cells is highly permeable
to water. Increases in intracellular osmolality (e.g., during trans-
epithelial transport, accumulation of osmolytes in metabolically
active cells, and ischemic hypoxia) or decreases in extracellular
osmolality will induce a rapid water influx across the cell mem-
brane, resulting in swelling of the cell. Multiple mechanisms
have been postulated to counteract the swelling and cause a reg-
ulatory volume decrease (RVD) through ion and osmolyte efflux
followed by release of osmotically obligated water. For example,
swelling-activated K+ channels and K+-Cl cotransporters are
thought to play a role (Hoffmann et al., 2009; Lang, 2007). In addi-tion, a large anion-selective current activated by swelling was
first described in human lymphocytes three decades ago (Caha-
lan and Lewis, 1988; Grinstein et al., 1982) and has been subse-
quently observed in virtually every vertebrate cell type examined
(Doroshenko and Neher, 1992; Jentsch et al., 2002; Nilius et al.,
1994; Okada, 1997). Under physiological conditions, this current
is primarily carried by chloride anions (and is commonly referred
to as ICl, swell) butmay alsomediate passive efflux of small organic
osmolytes, such as amino acids and their derivatives (Strange
et al., 1996). The activation of ICl, swell reduces the intracellular
osmolality and constitutes one of the major pathways respon-
sible for RVD (Hoffmann et al., 2009; Lang, 2007).
The channel underlying ICl, swell displays a characteristic
biophysical fingerprint including a low field strength anion
permeability sequence (I > Br > Cl > F), intermediate sin-
gle-channel conductance, and a mild outwardly rectifying cur-
rent-voltage (I-V) relationship (Jentsch et al., 2002; Nilius and
Droogmans, 2003; Okada et al., 2009; Strange et al., 1996).
Volume-regulated anion channel (VRAC) is also referred to by
other names, such as VSOR (volume-sensitive outwardly recti-
fying anion channel) and VSOAC (volume-sensitive organic
osmolyte anion channel). Although the pharmacological and
electrophysiological properties of VRAC have been described
in detail, its molecular identity has remained unknown (Hoffmann
et al., 2009; Nilius and Droogmans, 2003). Several candidates
have been proposed tomediate ICl, swell, but none have been vali-
dated by subsequent studies (Jentsch et al., 2002; Okada et al.,
1998). The lack of a specific high-affinity channel ligand hinders
direct purification of the channel protein. Expression cloning, an
otherwise powerful technique for ion channel identification (Hille,
2001), is severely hampered by high endogenous VRAC levels in
almost all cell types, including Xenopus oocytes (Ackerman
et al., 1994). Strong evidence supports bestrophin-1 (dBest1)
as forming the Drosophila ICl, swell channel (Chien and Hartzell,
2007; Stotz andClapham, 2012). However, the biophysical prop-
erties of this channel are distinct from vertebrate VRAC (Stotz
and Clapham, 2012), and ICl, swell is unimpaired in murine cells
with both mBest1 and mBest2 disrupted (Chien and Hartzell,
2008). This indicates that bestrophins are unlikely to mediate
VRAC in vertebrate cells.Cell 157, 447–458, April 10, 2014 ª2014 Elsevier Inc. 447
Figure 1. Hypotonicity-Induced YFP Quenching Assay
(A) Representative traces of fluorescence change (normalized to the baseline immediately before the addition of NaI) in HEK-YFP cells under different hypotonic
stimuli (HYPO) in mOsm/kg as monitored by the Fluorometric Imaging Plate Reader.
(B) Hypotonicity-induced quenching responses (mean ± SEM, n = 4) during increasing hypotonic stimuli.
(C) Concentration-response relationship for DCPIB to the quenching response induced by 215 mOsm/kg. Each data point is mean ± SEM, n = 8.
See also Figure S1 and Table S1.In this study, we established a cell-based fluorescence assay
for hypotonicity-induced iodide influx and performed a genome-
wide RNAi screen in HEK293T cells. This strategy has enabled
us to identify SWELL1 (LRRC8A), a ubiquitously expressed but
poorly characterized transmembrane protein with many
leucine-rich repeats, as an essential component of the VRAC
channel. We show that SWELL1 is localized to the plasma mem-
brane and that its knockdown dramatically suppresses native
VRAC currents in multiple cell types. This deficit can be rescued
by expression of RNAi-insensitive SWELL1 complementary DNA
(cDNA) clones. Mutagenesis analysis further suggests that
SWELL1 is near or part of the pore of the VRACchannel complex.
RESULTS
Genome-wide RNAi Screen Identifies LRRC8A as
Essential for Hypotonicity-Induced Iodide Influx
To search for genes encoding VRAC or its regulators, we devel-
oped a high-throughput cell-based fluorescence assay for
ICl, swell activity in 384-well format using an automated Fluoro-
metric Imaging Plate Reader (FLIPR). HEK293T cells stably ex-
pressing the halide-sensitive yellow fluorescent protein (YFP)
(Galietta et al., 2001) were first stimulated with hypotonic solu-
tions for 5 min to elicit a large endogenous ICl, swell current (He´lix
et al., 2003). A subsequent addition of NaI triggered a rapid fluo-
rescence decrease due to I influx through VRAC (Figure 1A).
The degree of fluorescence quenching correlated with the
strength of the hypotonic stimulus and reached a peak of
70% reduction at a final osmolality of 215mOsm/kg (Figure 1B;
Table S1). The YFP quenching response was strongly inhibited
by DCPIB (4-(2-butyl-6, 7-dichloro-2-cyclopentyl-indan-1-on-
5-yl) oxobutyric acid), a potent VRAC antagonist (Decher et al.,
2001), with an IC50 of 20.9 mM (Figure 1C). These data confirm
the validity of this assay and indicate a large assay window. Cells
transfected with small interfering RNA (siRNA) against several
previously proposed VRAC candidates (ICln, CLC-2, CLC-3,
and BEST1) (Hoffmann et al., 2009) showed normal hypo-
tonicity-induced YFP quenching responses, similar to cells
treated with scrambled siRNA (Figure S1 available online), indi-
cating that these proteins are not by themselves required for
VRAC activity in HEK293T cells.448 Cell 157, 447–458, April 10, 2014 ª2014 Elsevier Inc.To identify VRAC molecular components, we performed an
unbiased genome-wide RNAi screen with an arrayed siRNA
library (QIAGEN) targeting 17,631 known and 4,837 predicted
human genes (Zhang et al., 2009) (see Experimental Proce-
dures). We initially focused our attention on proteins predicted
to have at least one transmembrane (TM) domain (a feature
shared by all ion channels). The knockdown of500 such genes
reduced hypotonicity-induced YFP quenching responses to
various degrees. From this list, we manually inspected baseline
fluorescence and hypotonicity-induced fluorescence changes
to eliminate many false positives identified due to cell death or
cell detachment upon knockdown. We picked 51 candidate
genes with unknown or poorly defined function and evaluated
them in a secondary RNAi screen using smartpool siRNAs
(a mix of four individual siRNAs against different regions of the
transcript) from a different source (Dharmacon). Knockdown of
LRRC8A (leucine-rich repeat-containing protein 8A) caused a
pronounced decrease of hypotonicity-induced YFP quenching
(Figures 2A and 2B) without affecting the basal fluorescent levels
of transfected cells (data not shown). The siRNA-mediated inhi-
bition was as efficacious as the VRAC antagonist DCPIB. Atten-
uation of quenching responses was observed with individual
siRNAs targeting distinct regions of the transcript (Figure 2C),
suggesting an on-target mechanism of action of these siRNAs.
All siRNAs tested reduced the abundance of the target tran-
scripts as assayed with quantitative polymerase chain reaction
(qPCR) (Figure S2A). Since LRRC8A (also called LRRC8 or
AGM5) appears to encode a protein required for an anion flux
in response to cell swelling, we named this gene SWELL1.
SWELL1 Is Required for VRAC Channel Activity in
Various Cell Types
We next used established conventional whole-cell patch-clamp
recording protocols to assay ICl, swell activity in the presence
and absence of SWELL1 (He´lix et al., 2003; Lewis et al., 1993;
Shen et al., 2000). Three days after transient transfection of
HEK293T cells with scrambled siRNA or siRNA against SWELL1,
cells from both conditions revealed similar low background
conductance in isotonic solution indicating SWELL1 siRNA
treatment had no detectable influence on cell health (Figure 3A,
Table S2). Hypotonic solutions elicited large increases in
Figure 2. SWELL1 Is Essential for Hypotonicity-Induced Iodide Influx
(A) Hypotonicity-induced quenching responses (mean ± SEM, n = 3–4) in HEK-YFP cells transfected with scrambled siRNA or siRNA against 51 candidate genes.
(B) Representative traces of fluorescence change in HEK-YFP cells transfected with either scrambled siRNA or SWELL1 siRNA. Cells treated with 50 mMDCPIB
were used as a positive control.
(C) Hypotonicity-induced quenching responses (mean ± SEM; n = 4) in HEK-YFP cells transfected with either scrambled siRNA or various individual SWELL1
siRNAs present in the smartpool.
See also Figure S2.conductance in scrambled siRNA-transfected cells after a short
lag (Figures 3A and 3B). These currents had characteristics
typical of ICl, swell (Figures S3A–S3E): voltage-independent block
by DCPIB, voltage-dependent inhibition by DIDS (4,4’ diisothio-
cyanatostilbene-2,2’-disulfonic acid), largely permeable to Cl
(see Experimental Procedures) and mild outwardly rectifying.
Remarkably, the response of SWELL1 siRNA-treated cells to a
hypotonic stimulus was dramatically suppressed (Figures 3A
and 3B).
To test whether SWELL1 is also essential for VRAC channel
activity in other cell types, we investigated ICl, swell in both
HeLa cells and primary human CD4+ T lymphocytes where
VRACwas first recorded (Cahalan and Lewis, 1988). VRAC activ-
ity in both cell types had similar overall properties to those in
HEK293T cells, including moderate outward rectification and
block by DCPIB and DIDS (Figures S3F–S3L). Once again, we
observed a robust suppression of VRAC by targeting SWELL1
through siRNA transfection in HeLa cells (Figures 3C and 3D)
and lentiviral transduction of short hairpin RNA (shRNA) in T lym-
phocytes (Figures 3E and 3F). Thus, endogenous ICl, swell withtypical VRAC features are dramatically inhibited by SWELL1
knockdown in all three cell types tested.
Expression Profile and Localization of SWELL1
SWELL1 (LRRC8A) is predicted to contain 4 TM helices and 17
leucine-rich repeats and was first cloned from an agammaglob-
ulinemia patient who lacked circulating B cells (Sawada et al.,
2003). A heterozygous mutation, SWELL1D91/+35 (91 C-terminal
amino acids were replaced by 35 amino acids encoded by intron
sequences), was proposed as the cause of the disease. SWELL1
is conserved across vertebrate species and four other homolo-
gous family members (LRRC8B-8E) are usually present in their
genomes (Abascal and Zardoya, 2012; Kubota et al., 2004).
The functions of SWELL1 and its family members are unknown.
However, a recent sequence comparison analysis of their TM
domains suggests that they are distantly related to pannexin
ion channels (Abascal and Zardoya, 2012). RNAi knockdown of
each of the four SWELL1 homologs had little effect on hypo-
tonicity-induced YFP quenching responses (Figures S2B and
S2C). This suggests that, unlike SWELL1, the other membersCell 157, 447–458, April 10, 2014 ª2014 Elsevier Inc. 449
Figure 3. SWELL1 Knockdown Abolishes Endogenous VRAC Currents in Multiple Cell Types
(A) Whole-cell currents monitored by voltage step (left) and ramp (right) protocols in isotonic solution (ISO; black traces) and after 6 min in hypotonic solution (210
mOsm/kg HYPO; green traces) shown for representative HEK293T cells transfected with either scrambled or SWELL1 siRNA.
(B) Average current densities at100mV (below x axis) and +100mV (above x axis) over time induced by the 210 mOsm/kg HYPO stimulus (applied at the arrow)
for HEK293T cells.
(C) Whole-cell currents monitored by voltage ramp protocol from representative HeLa cells transfected with either scrambled or SWELL1 siRNA in ISO (black
trace) and 230 mOsm/kg HYPO (green trace) solutions.
(D) Average current densities at 100 mV and +100 mV over time induced by the 230 mOsm/kg HYPO stimulus (applied at the arrow) for HeLa cells.
(E) Whole-cell currents monitored by voltage ramp protocol from representative primary human CD4+ T lymphocytes transduced with lentiviruses expressing
shRNAs targeting firefly luciferase (control) or SWELL1 in ISO (black trace) and 260 mOsm/kg HYPO (green trace) solutions.
(F) Average current densities at 100 mV and +100 mV over time induced by the 260 mOsm/kg HYPO stimulus (applied at the arrow) for T lymphocytes.
Error bars representmean±SEM, andnumber of recordedcells is indicated for at least four separate experiments.Unapparent error bars are smaller than symbols.
See also Figure S3 and Table S2.
450 Cell 157, 447–458, April 10, 2014 ª2014 Elsevier Inc.
S
w
el
l1
 m
R
N
A 
le
ve
l
0
20
40
60
80
100
120
A
B
C
N-Myc 306-Myc98-Myc C-Myc
A
nt
i-M
yc
M
er
ge
 w
ith
 G
FP
N
on
-p
er
m
ea
bi
liz
ed
A
nt
i-M
yc
P
er
m
ea
bi
liz
ed
TM
1
TM
2
TM
3
TM
4
NH2
COOH
Extracellular
Intracellular
bra
in
sk
in
T c
ell
ma
cro
ph
ag
e
lun
g
sm
all
 in
tes
tin
e
liv
er
pa
nc
rea
s
kid
ne
y
he
art
DR
G
B 
ce
ll
Figure 4. Swell1 Is Expressed Broadly in Mouse Tissues and Is
Present at the Plasma Membrane
(A) mRNA expression profile of murine Swell1 determined by qPCR. Gapdh
was used as the reference gene. Expression levels were normalized to lung as
100 and presented as mean ± SEM (n = 2–3). DRG: dorsal root ganglion.
(B) Nonpermeabilized and permeabilized HEK293T cells expressing SWELL1
with Myc tag inserted in various positions were immunostained with anti-Myc
antibody. Scale bars: 5 mm.
(C) Schematic representation of the membrane topology of SWELL1 based on
our results and the modeled structure of the LRR domains according to X-ray
structure (Protein Data Bank ID 3cigA) of the homologous LRR domains of
mouse Toll-like receptor 3. The sites of Myc tags (red circles) are indicated.
See also Figure S4.of this family are not by themselves essential for hypotonicity-
induced iodide influx in HEK293T cells.
Swell1 mRNA was detected broadly in mouse tissues (Fig-
ure 4A) (Kubota et al., 2004), consistent with the ubiquitous pres-
ence of the VRAC channel. Relatively high expression of Swell1
was observed in B and T cells, supporting a potential role in im-
mune cell function (Sawada et al., 2003). If SWELL1 is a compo-
nent of the VRAC channel complex, it should be present at the
plasma membrane. To examine whether SWELL1 is expressed
at the cell surface, we inserted Myc tags at several sites in the
gene and transfected the constructs into HEK293T cells. The
plasma membrane localization of SWELL1 was detected by
immunofluorescent staining in intact (nonpermeabilized) cells
expressing Myc-tagged constructs with the epitopes inserted
after residues 98 (putative TM1-TM2 loop) or 306 (putative
TM3-TM4 loop) (Figure 4B). In contrast, Myc tags located at
either end of the protein were detected only after cell permeabi-
lization (Figure 4B). These data suggest that contrary to previous
suggestion (Sawada et al., 2003), the leucine-rich repeats of
SWELL1 are in the cytoplasm (Figure 4C), confirming a recent
bioinformatics prediction (Abascal and Zardoya, 2012).
SWELL1 Does Not by Itself Generate Larger VRAC
Currents
Given that SWELL1 knockdown inhibited VRAC activation,
we tested whether SWELL1 overexpression would enhance
ICl, swell current density. We transiently transfected HEK293T
and HeLa cells with pIRES2-EGFP carrying the human SWELL1
coding sequence (untagged) and recorded ICl, swell from GFP-
positive cells in thewhole-cell configuration one day later. During
hypotonic stimulation to either HEK293T (Figure S4A) or HeLa
cells (data not shown) overexpressing SWELL1, ICl, swell was
not enhanced compared to that in control cells. On the con-
trary, SWELL1 overexpression resulted in decreased VRAC
currents when assayed 2–3 days after transfection (data not
shown). Expression of heterologous SWELL1 (FLAG-tagged) in
HEK293T cells was verified by immunoprecipitation followed
by western blot with an antibody against SWELL1 (Figure S4B).
Note that this SWELL1 antibody was not sensitive enough to
detect expression of endogenous SWELL1 in HEK293T or
HeLa cells. These results indicate that extra SWELL1, although
detected on the cell surface (Figure 4B), does not by itself
generate larger ICl, swell. ICl, swell amplitudes were not significantly
diminished or enhanced upon overexpression of disease mutant
SWELL1D91/+35 (Figure S4A), suggesting that the mutant has no
apparent dominant-negative or gain-of-function effect on VRAC
activity in these cell lines.
SWELL1 Is a Component of the VRAC Channel Complex
To exclude the possibility of an off-target effect of SWELL1
knockdown on VRAC activity, we performed cDNA rescue
experiments in stable SWELL1 knockdown cells. We transduced
HeLa or HEK-YFP cells with lentiviruses carrying a SWELL1
shRNA and established stable knockdown cell lines. We then
transiently transfected RNAi-insensitive SWELL1 cDNA
clones harboring five synonymous mutations within the shRNA
target sequence and recorded whole-cell currents from
transfected cells. As shown in Figure 5A, compared to vectorCell 157, 447–458, April 10, 2014 ª2014 Elsevier Inc. 451
Figure 5. CurrentsMediated byCysteine Substitution of Threonine Residue (T44) in SWELL1 Are Acutely and Essentially Irreversibly Inhibited
by the Application of Cysteine-Reactive MTSES
(A) Average current densities at 100 mV and +100 mV over time induced by the 230 mOsm/kg HYPO solution (applied at the arrow) for HeLa cells or stable
SWELL1 knockdown HeLa cells expressing RNAi-insensitive SWELL1 or SWELL1D91/+35.
(B) HYPO-induced currents (n = 3) in stable SWELL1 knockdown HeLa cells expressing RNAi-insensitive WT SWELL1 are strongly inhibited by DCPIB (20 mM).
(C) Hypotonicity-induced quenching responses (n = 4) in stable SWELL1 knockdown HEK-YFP cells expressing RNAi-insensitive SWELL1 or SWELL1D91/+35.
(D) Inhibition by MTSES application (n = 3–5) on the rescue activity of hypotonicity-induced quenching response in stable SWELL1 knockdown HEK-YFP cells
expressing RNAi-insensitive WT SWELL1 or SWELL1 mutants with cysteine individually substituted in four putative TM domains. Red dashed lines indicate two-
fold background MTSES inhibition (18.9%) observed in WT SWELL1-mediated rescue activity. T44C (red box) is the only mutant whose rescue activity was
significantly reduced by MTSES above the cut-off line.
(E) Representative examples of the effect of MTSES application (red) on hypotonicity-induced currents for stable SWELL1 knockdown HeLa cells expressing
RNAi-insensitive WT SWELL1 or SWELL1 (T44C).
(legend continued on next page)
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alone, expression of RNAi-insensitive wild-type (WT) SWELL1
in stable knockdown HeLa cells restored hypotonicity-
induced currents, which have many key features of parental
ICl, swell, such as mild outward rectification and voltage inde-
pendent inhibition by DCPIB (Figure 5B). Besides hypotonicity-
induced cell swelling, VRAC is also activated by reduced
intracellular ionic strength under constant-volume conditions
(Voets et al., 1999). Consistent with SWELL1 being essential
for VRAC activity, a reduction of intracellular ion strength acti-
vated DCPIB-sensitive currents in control cells, but not in
SWELL1 stable knockdown cells (Figures S5A–S5C and data
not shown). Importantly, expression of RNAi-insensitive WT
SWELL1 rescued this activity (Figures S5A–S5C). These data
confirm that the observed RNAi phenotype is due to silencing
of SWELL1.
Expression of RNAi-insensitive SWELL1D91/+35 in stable
knockdown cells failed to generate any ICl, swell current above
the background (Figure 5A), indicating that this mutation is not
functional in this assay. We further performed a similar cDNA
rescue experiment in stable SWELL1 knockdown HEK-YFP
cells using the fluorescence reporter assay. Consistent with
the electrophysiological data, expression of WT SWELL1, but
not disease mutant SWELL1D91/+35, increased hypotonicity-
induced iodide influx compared to vector control (Figure 5C).
Our in vitro findings that SWELL1D91/+35 mutant lacks VRAC
function and exhibits no prominent dominant negative activity
suggest that this ion channel might be involved in regulating
the maturation of human B cells. Whether the heterozygous mu-
tation that expresses the SWELL1D91/+35 allele causes agamma-
globulinemia by simple haploinsufficiency of SWELL1 or other
possible mechanisms will have to be evaluated in the future
(Sawada et al., 2003).
The evidence thus far suggests that SWELL1 is required for
VRAC. SWELL1 could be part of VRAC channel complex; how-
ever, it is also possible that SWELL1 regulates VRAC activity
indirectly, for example by controlling channel expression or traf-
ficking. To distinguish these two possibilities, we used the
substituted cysteine accessibility method (SCAM) to identify
SWELL1 residues which when mutated to cysteine can react
with a thiol-reactive reagent (Karlin and Akabas, 1998). If such
reactions cause acute and irreversible alterations in the channel
activity, it would suggest that SWELL1 is an integral component
of the VRAC complex. For this purpose, we chose negatively
charged membrane-impermeable 2-sulfonatoethyl methane-
thiosulfonate (MTSES) and observed no apparent effect of extra-
cellular MTSES (3.33 mM) on ICl, swell reconstituted by WT
SWELL1 in stable knockdown HeLa cells (see below). This indi-
cates that endogenous SWELL1 cysteines accessible from the
extracellular side either do not react with MTSES or, if they do,
do not interfere with channel activation.
We then systematically substituted cysteines individually into
all four putative TM domains of SWELL1. To facilitate the
SCAM screen, we took advantage of the fluorescence reporter(F) Current traces acquired using a ramp protocol at the indicated time points
partially blocked after MTSES exposure (c).
(G) MTSES-induced block on recue currents mediated by WT SWELL1 (n = 13) a
Error bars represent mean ± SEM. See also Figure S5.assay in stable SWELL1 knockdown HEK-YFP cells. We
observed a small decrease (10%) of WT SWELL1-mediated
rescue activity by MTSES application during hypotonic stimula-
tion (Figure 5D), which is likely a background response specific
to this assay since no inhibition was detected by electrophysio-
logical recordings (Figures 5E and 5G). Of the 76 mutants, 62
produced relatively normal cDNA rescue activities (defined as
>60% of the activity mediated by WT SWELL1) (Figure S5D).
We then screened the 62 functional mutants with MTSES appli-
cation, and observed that cysteine replacement of threonine at
position 44 (T44C) stood out, as MTSES substantially reduced
its activity (Figure 5D). Whole-cell patch-clamp recordings
of stable SWELL1 knockdown HeLa cells expressing T44C
revealed that extracellular MTSES rapidly suppressed T44C-
mediated currents (Figure 5E, bottom). The effect persisted after
MTSES washout (Figure S5E), consistent with covalent modifi-
cation of the protein. MTSES-induced inhibition was more
pronounced for inward currents (Cl efflux) than outward cur-
rents (Cl influx) (Figure 5E–5G), which made ICl, swell more
outwardly rectifying. These results, combined with the RNAi
study, suggest that SWELL1 is an essential component of the
VRAC complex.
Ion selectivity of a channel is determined by its pore, or in
rare cases, by pore-associated subunits (Hille, 2001). Thus,
the ability to change selectivity by a point mutation would pro-
vide strong evidence that SWELL1 forms or is at least very close
to the VRAC channel pore. Since a permeability preference of
I > Cl is characteristic of VRAC, we estimated permeability
ratios (PI/PCl) from the difference in reversal potential (Vrev)
observed where equimolar I or Cl was the only permeant
extracellular anion. Endogenous ICl, swell in HeLa cells and WT
SWELL1-mediated rescue currents in stable knockdown cells
were similar (PI/PCl: 1.3) (Figures 6A and 6C), confirming a
preference for I over Cl. While Vrev in the Cl
-containing
solution was similar (Figures 6A and 6B), Vrev in the I
 solution
for T44C-mediated rescue currents was dramatically shifted to
more negative potentials compared to WT SWELL1-mediated
currents and endogenous ICl, swell in HeLa cells (Figures 6A
and 6B). These data indicate that T44C mutant is more perme-
able to I than controls (Figure 6C). The shift of Vrev in the I
 so-
lution is not dependent on the current density (Figure S6). We
also mutated T44 to an acidic (glutamic acid, E) or basic (argi-
nine, R) residue to determine whether the anion permeability
could be altered. Although T44E-mediated rescue currents
were similar to controls (Figures 6A and 6C), currents from
T44R showed a significant reduction of I selectivity (PI/PCl:
1.15, Figures 6A–6C). Therefore, data from two independent
substitutions argue that T44 has a sizeable impact on anion
permeability. The mechanism of how the pore is affected by
these mutations (e.g., side chain bulkiness or pKa) is beyond
the scope of this current work but these data support the
conclusion that SWELL1 is close to or forms the pore of the
VRAC channel complex.in E (bottom) show outwardly rectifying hypotonicity-induced currents (b) are
nd T44C (n = 10) at 100 mV and +100 mV.
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Figure 6. T44C and T44R Mutations
of SWELL1 Alter the Anion Selectivity of
ICl, swell
(A) Reversal potentials (Vrev) determined under
identical conditions other than the extracellular
anion (iodide or chloride) for VRAC currents re-
corded from HeLa cells or stable SWELL1
knockdown HeLa cells expressing WT or mutated
SWELL1. Bars represent mean ± SEM (***p <
0.001, n.s., not significant).
(B) I-V relationships recorded in extracellular I
and Cl solutions in stable SWELL1 knockdown
HeLa cells expressing WT or mutated SWELL1.
Arrows indicate Vrev for each cell. The larger the
difference between Vrev in I
 and Cl solution, the
larger the selectivity for I over Cl.
(C) PI/PCl values were calculated based on the
data shown in (A) (see Experimental Procedures).
Values in parentheses indicate the compound
SEM for the calculation.
See also Figure S6.SWELL1 Contributes to Regulatory Volume Decrease
To test whether diminished ICl, swell in SWELL1 knockdown
cells impair hypotonicity-induced RVD, we investigated HeLa
cells which are widely used in cell volume regulation studies
(Lang, 2007). No difference in cell volume with or without
SWELL1 knockdown was observed prior to hypotonic stimula-
tion (Figure S7A), suggesting that SWELL1 is not required for
cell volume homeostasis under iso-osmotic conditions. The
initial maximum volume increase after exposure to hypotonic
solution was also the same in cells transfected with SWELL1
siRNA compared to controls (Figure 7A, 1–3 min). However,
cell volume recovery was significantly slower in cells treated
with siRNA against SWELL1 (Figures 7A and 7B). This high-
lights an essential function of SWELL1 in maintaining cell vol-
ume homeostasis upon hypotonic challenge. The remaining
RVD activities are possibly due to residual SWELL1 protein
expression and other ion efflux pathways, such as swelling-
activated K+ channels and K+-Cl cotransporters (Hoffmann
et al., 2009). Besides loss of intracellular electrolytes, hypo-
tonicity-induced efflux of small organic osmolytes (such as
taurine, an abundant amino acid derivative) also contributes
to cell volume recovery. Although accumulating evidence sug-
gests that these osmolytes might be released from cells
through the VRAC channel, direct evidence is lacking due to
its unknown molecular identity. We observed a sharp increase
in the rate of taurine efflux after hypotonic stimulation in
scrambled siRNA-treated HeLa cells, and SWELL1 knockdown
dramatically blunted this response (Figure 7C). We also tested
if taurine permeates the VRAC channel (Manolopoulos et al.,
1997). Hypotonicity-induced whole-cell outward currents
were detected in HeLa cells but not in SWELL1 stable knock-
down cells when extracellular Cl was replaced by taurine (Fig-454 Cell 157, 447–458, April 10, 2014 ª2014 Elsevier Inc.ures S7B and S7C and data not
shown). Expression of RNAi-insensitive
WT SWELL1 rescued this activity (Fig-
ures S7B and S7C). These data areconsistent with VRAC mediating hypotonicity-induced taurine
flux in HeLa cells.
DISCUSSION
Through an unbiased genome-wide RNAi screen, we identify
SWELL1, and show that this multipass transmembrane protein
is an essential component of VRAC. The evidence to support
this conclusion includes: (1) SWELL1 expression is required for
the endogenous VRAC currents in various cell types, and for
regulation of cell volume homeostasis; (2) SWELL1 is a plasma
membrane protein, and its mRNA is broadly expressed in
mammalian tissues and cells; and (3) point mutations in SWELL1
cause a significant change in a VRAC pore property, specifically
I versus Cl selectivity.
The precise relation between SWELL1 and the VRAC channel
pore remains unclear. We show that mutations at SWELL1 T44
affect VRAC anion selectivity. Althoughmutagenesis that causes
a change in ion selectivity is often used as evidence that the site
is within the pore, potential exceptions to this rule have been
reported (Kaczmarek and Blumenthal, 1997). At least two possi-
bilities exist. On the one hand, SWELL1 could be a VRAC subunit
closely associated with the pore and required for modulating
channel properties, including ion selectivity, similar to KCNE
subunits (MinK family) of voltage-gated potassium channels
(Kaczmarek and Blumenthal, 1997). On the other hand, SWELL1
could constitute a pore-forming subunit, which would be con-
sistent with the prediction that LRRC8 proteins are evolutionarily
related to pannexin channels. We confirmed experimentally that
SWELL1 indeed contains four TM domains with cytoplasmic N
and C termini, which is a basic structural feature shared by a
superfamily of evolutionarily distinct and functionally diverse
Figure 7. SWELL1 Contributes to Regulatory Volume Decrease and Is Required for Hypotonicity-Induced Taurine Release
(A) Time course of relative cell volume change after the exposure to hypotonic solution (220mOsm/kg, indicated by the arrow) in HeLa cells transfectedwith either
scrambled siRNA or siRNA against SWELL1. Each data point represents the mean ± SEM (n = 5).
(B) RVD time constants were determined using one-phase exponential decay curve fitting for data shown in (A). Bars represent mean ± SEM (***p < 0.001).
(C) Time course of the rate constant for swelling-induced [H3]taurine efflux after the exposure of hypotonic solution (210mOsm/kg, indicated by the arrow) in HeLa
cells transfected with either scrambled siRNA or siRNA against SWELL1. Each data point represents the mean ± SEM (n = 3).
See also Figure S7.ion channels, including pannexin (its invertebrate homolog in-
nexin), gap junction-forming connexin, and more recently identi-
fied CALHM (calcium homeostasis modulator) families (Siebert
et al., 2013). Interestingly, T44 of SWELL1 is predicted to be in
the external portion of TM1, and the equivalent regions of con-
nexins and pannexins are thought to line part of their pores
based on X-ray crystal structure and SCAM analysis (Maeda
et al., 2009; Wang and Dahl, 2010). Other than T44C, cysteine
mutants in other regions of the four putative TM domains were
not affected upon MTSES application. This could be explained
by the low sensitivity of fluorescence assay we used, or the
choice of MTSES as cysteine-reactive reagent. It is also possible
that the remaining part of the VRAC pore is formed by other sub-
units (see below), or other regions of SWELL1 including the
extracellular loops, or N or C terminus (as is the case for both
connexins and pannexins) (Maeda et al., 2009; Wang and Dahl,
2010). Regardless, our data allow us to conclude that SWELL1
is an essential component of VRAC that is either pore-forming
or is closely-associated with the pore.
Extra SWELL1 expression, although detected on the cell
surface, did not induce larger ICl, swell. Overexpressing essential
subunits of ion channels does not always lead to increased
channel activity. There are various reasons for lack of sufficiency.
For example, it could be due to a limiting factor upstream of
VRAC channel activation, such as a putative cell volume sensor
(it is not clear if VRAC itself senses cell volume change). Pore-
forming ORAI1 ion channel is such an example, which requires
the calcium sensor STIM1 to reconstitute store-operated cal-
cium channel function (Cahalan, 2009). Alternatively, SWELL1
could be one of the subunits in a multimeric channel complex.
In this scenario, the other subunit(s) could be the limiting factor(s)
during overexpression, like in the case of pentameric hetero-
oligomers of ligand-gated ion channels (Minier and Sigel,
2004). Future studies will determine the full molecular composi-
tion of the VRAC channel complex and the precise relation
between SWELL1 and the channel pore.
In conclusion, the identification of SWELL1 as a long-sought
VRAC component has allowed us to provide strong support for
the contribution of the VRAC channel to cell volume regulationand hypotonicity-induced taurine efflux. Besides cell volume
regulation, the VRAC channel is also implicated in many other
processes including regulation of membrane potential, salt
and fluid secretion, glutamate release, cell proliferation, and
apoptosis (Nilius and Droogmans, 2003; Okada et al., 2009).
This discovery will now enable further molecular characterization
of this ion channel complex, as well as a genetic approach to
understand its role in physiology and disease. In addition, our
finding that an essential VRAC component belongs to the evolu-
tionarily conserved LRRC8 family raises the question whether
other LRRC8 family members are also associated with anion
channels or transporters in vertebrate species.EXPERIMENTAL PROCEDURES
Additional information regarding plasmids, siRNA library, cell culture, qPCR
assay, and detailed procedures for western blot and electrophysiology are
described in the Extended Experimental Procedures.Hypotonicity-Induced YFP Quenching Assay
A cell-based assay using the halide-sensitive YFP (with H148Q and I152L
mutations) was described previously (Galietta et al., 2001). HEK293T cells
were transfected with the plasmid carrying the halide-sensitive YFP. Stably
transfected and single-cell derived clones (HEK-YFP) were isolated by
FACS. HEK-YFP cells in 384 well plates were washed and kept in 20 ml/well
isotonic solution (in mM): 140 NaCl, 5 KCl, 20 HEPES (310 mOsm/kg; pH 7.4
with NaOH). A serial dilution of hypotonic solutions was made by omitting
NaCl and adding different amounts of mannitol (Table S1). Osmolalites of all
the solutions were measured by Vapor Pressure Osmometer 5600. We stimu-
lated cells with 20 ml/well hypotonic solutions for 5 min, followed by addition of
10 ml/well 200 mM NaI. FLIPR (Molecular Devices) recorded fluorescence in
each well simultaneously during the assay. The fluorescence reading at 20 s
after NaI addition was normalized to that at 5 s before the addition (set as
100%). The percentage of fluorescence decrease after NaI addition was calcu-
lated as the YFP quenching response. All subsequent YFP quenching assays
(except the initial experiment in Figure 1A) used hypotonic solution (in mM): 5
KCl, 20 HEPES, 90 mannitol (120 mOsm/kg). For the SCAM screen, we
incubated SWELL1 cDNA-rescued cells with 10 mM MTSES in hypotonic
solution for 5 min before the regular FLIPR assay described above. For siRNA
transfection in 384-well plates, we first added 20 ml Opti-MEMwith 0.15 ml Lip-
ofectamine RNAiMAX (Life Technologies) and 1 pmol smartpool siRNAs (Dhar-
macon) to each well, incubated them for 20 min, and added 20 ml of HEK-YFPCell 157, 447–458, April 10, 2014 ª2014 Elsevier Inc. 455
cells (104 cells/well). The cells were incubated at 37C for 3 days before the
assay.
Genome-wide RNAi Screen
The siRNA library (QIAGEN) was previously described (Zhang et al., 2009).
siRNA transfections for a total of 292 plates in HEK-YFP cells were performed
as described above except using a GNF robotic system. The hypotonicity-
induced YFP quenching response was calculated and then normalized to
the plate average (set as 1). The average score of two duplicates was
determined for each well. The well was considered a hit when its score was
2 standard deviations below the mean. For the follow-up RNAi screen, we
transfected cells with smartpool siRNAs (Dharmacon) against 51 candidate
genes encoding putative membrane proteins, and assayed for the hypo-
tonicity-induced YFP quenching response. As controls, scrambled siRNA
duplexes (QIAGEN) were employed.
Cell Culture
Cells were maintained in standard culture conditions. For siRNA experiments,
cells were cotransfected with 25 nM siRNA and 500 ng/ml GFP vector using
Lipofectamine 2000 (Life Technologies) to identify transfected cells, seeded
on 12 mm diameter poly-D-lysine coated glass coverslips (BD) in 24-well
dishes, and were recorded 3 days after transfection. For SWELL1 overexpres-
sion experiments, 500 ng/ml SWELL1 or SWELL1D91/+35 pIRES2-EGFP con-
structs or pIRES2-EGFP vector were transfected and cells were recorded
18–30 hr later.
Lentivrial shRNA and Stable Knockdown
SWELL1 shRNA with the same sequence as the most potent siRNA (#1) was
inserted into pLL3.7 and pLKO.1 vector (Addgene). Lentiviruses were pro-
duced by cotransfecting HEK293T cells with SWELL1 shRNA constructs,
pMD2.G, pRSV-REV, and pMDL.RRE following Addgene’s instruction. Pri-
mary CD4+ lymphocytes were transduced with SWELL1 shRNA lentiviruses
(pLL3.7 based) using RetroNectin reagent as described by the manufacturer
(Takara), and infected cells (GFP+) were recorded 3 days after transduction.
We used lentiviruses carrying shRNA targeting luciferase gene as controls.
HeLa or HEK-YFP cells were transduced with SWELL1 shRNA lentiviruses
(pLKO.1 based), selected with puromycin (2 mg/ml) 48 hr posttransduction
for 2 weeks. Stable knockdown cell lines were derived from single-cell col-
onies and used for cDNA rescue experiments. Knockdown was assessed by
qPCR.
Electrophysiology
Whole-cell patch-clamp recordingswere performed as described (Dubin et al.,
2012), except that standard methods to achieve low access resistance (Ra)
were performed and solutions were adapted from previous studies (He´lix
et al., 2003; Jackson and Strange, 1996; Shen et al., 2000). Cells were contin-
uously perfused with extracellular solution (in mM): 90 NaCl, 2 KCl, 1 MgCl2, 1
CaCl2, 10 HEPES, 110mannitol (300mOsm/kg; pH 7.4 with NaOH). Hypotonic
solutions (HYPO) had the same ionic composition but contained either 10 mM
(HEK293T) or 30 mM (HeLa) or 60 mM (lymphocytes) mannitol instead of
110 mM. When HYPO was applied, only one cell was tested per coverslip.
Recording pipettes were usually filled with intracellular solution containing
(in mM) 133 CsCl, 5 EGTA, 2 CaCl2, 1 MgCl2, 10 HEPES, 4 Mg-ATP, 0.5 Na-
GTP (pH 7.3 with CsOH; 106 nM free Ca2+) and had resistances of 2–3 MU.
For lymphocyte recordings and initial Cl dependence studies, the intracellular
solution contained (in mM): 40 CsCl, 100 gluconate, 1 MgCl2, 1.93 CaCl2, 5
EGTA, 10 HEPES, 4 Na2-ATP, 0.5 Na-GTP (pH 7.3 with CsOH). The reversal
potential of ICl, swell was +10.0 ± 1.3 mV (n = 21) where ECl = +9.5 mV
(139 mM intracellular Cl), and –18.2 ± 4.2 mV (n = 3) in gluconate-containing
intracellular solution where ECl = –16 mV (50.6 mM intracellular Cl
), indicating
a large contribution of Cl to the currents.
For bianionic experiments, recording pipettes contained 140 CsCl/10
HEPES/4 Mg-ATP (required for VRAC activity), pH 7.3 and 88 Na-X/10
HEPES/mannitol (110 or 30 mM), pH 7.4 was bath applied, where X was either
Cl or I. An agar bridge containing 1 M KCl connected the headstage ground
to the bath. Families of currents were elicited by 100 or 840 ms steps from a
50 mV (50 ms) prepulse potential to +120 to120 mV in20 mV increments456 Cell 157, 447–458, April 10, 2014 ª2014 Elsevier Inc.every 10 s to determine voltage-dependent activation and inactivation proper-
ties of currents before and after challenge with HYPO. The holding potential
was 0 mV. VRAC currents in HYPO were slowly inactivating at positive poten-
tials. Voltage ramps were applied every 5 s from 100 to +100 mV at a ramp
speed 1.1 mV/ms. Sampling interval: 50 ms; filter: 10 KHz.
For the SCAM analysis, solutions containing MTSES (0.1–3.33 mM) were
bath applied near the plateau of ICl, swell for 2–5 min. MTSES decreased
T44C-mediated rescue currents with a latency of 20 s. The percent block
between 30–90 s was determined either by fitting the activation curves and
comparing the fit current magnitude to the actual data (when MTSES was
applied prior to current plateau) or by using current values just prior to MTS
exposure (when MTSES arrived during a plateau). MTSES was washed out
and the current recovery was determined by using either the fitted curve
data points or the plateau current data. Data were analyzed offline using
PClamp Clampfit10 and GraphPad Prism 6. PI/PCl was determined using the
equation = exp (((Vrev, I  Vrev, Cl))*1/25.693) (Shen et al., 2000). The
compound error in this difference calculation was determined as described
in (Taylor, 1982).
Quantitative Real-Time PCR
Total RNA was reverse transcribed to generate cDNA, which was then used as
templates for real-time PCR on ABI 7900HT fast real time system. Gene
expression was normalized to GAPDH.
Immunostaining
Immunostaining was performed as previously described (Schmidt et al., 2009).
For live-cell staining, cells were incubated with anti-Myc (9E11) antibody (1:50;
Santa Cruz Biotech) at 37C for 20 min followed by incubation with secondary
antibody at room temperature for 10 min. Cells were then fixed with 2%
paraformaldehyde (PFA). For regular immunocytochemistry, cells were fixed
with 4% PFA, incubated with anti-Myc antibody (1:500) for 2 hr and secondary
antibody for 1 hr. Coverslips were mounted and imaged with Nikon C2
confocal microscope.
Western Blot Analysis
Immunoprecipitation and western blot were performed by standard protocols
with antibodies (Sigma) against FLAG tag (F3165) and SWELL1 (HPA016811).
Regulatory Volume Decrease
HeLa cells were transfected with 25 nM scrambled siRNA or siRNA against
SWELL1 in 24-well plate using Lipofectamine RNAiMAX. Three days post-
transfection, siRNA-transfected cells were digested and suspended in
11.5 ml PBS. Cell volume was measured by the Z2 Coulter counter (Beckman
Coulter). Cells within the diameter range of 10–25 mm (corresponding to a cell
volume range of 524–8,181 fL) were counted and the average cell volume of
more than 10,000 cells in each counting run was recorded. After three
measurements, 8 ml hypotonic solution (the same as used in the RNAi screen)
was added to the cell suspension and a series of measurements was taken
until the restoration of the initial volume for cells treated with scrambled siRNA.
The average cell volume one min before the hypotonic stimulus was normal-
ized as 1 and the relative average volume at other time points was calculated.
RVD time constants were determined using one-phase exponential decay
curve fitting (GraphPad Prism 6).
Taurine Efflux Assay
Taurine efflux assay was performed as described previously (Falktoft and
Lambert, 2004). siRNA-transfected HeLa cells in six-well plates were loaded
with culture medium containing [3H]taurine (2 mCi/ml) at 37C for 2 hr. The cells
were washed five times with isotonic solution (in mM): 145 NaCl, 2 KCl, 1
MgCl2, 1 CaCl2, 10 HEPES, pH 7.4 (adjusted with NaOH). Hypotonic solution
was made by decreasing NaCl concentration to 95 mM. The experiment was
performed by removal/addition of 1 ml aliquots of solutions at 2 min intervals.
The effluxwas initiated by aspiration of isotonic solution followed by addition of
hypotonic solution. The cells were lysed at the end of the experiment with
0.5 M NaOH. The total 3H activity in the cells was estimated as the sum of
3H activity in all efflux samples and the final lysates using a Beckman Coulter
LS 6500 liquid scintillation counter. The natural logarithm to the fraction of 3H
activity remaining in the cells was plotted versus time, and the rate constant
for the taurine efflux (min1) at each time point was subsequently estimated
as the negative slope of the curve between the time point and the proceeding
time point (Falktoft and Lambert, 2004).
Data Analysis
Statistical significance was evaluated using unpaired two-tailed Student’s
t test for comparing difference between two samples.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and two tables and can be foundwith this article online at http://dx.doi.
org/10.1016/j.cell.2014.03.024.
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